Content area

|
|

Utilsigtede hændelser med orale antikoagulantia

Multifarmakologisk behandling øger risikoen for utilsigtede hændelser.
Forfatter(e)
Ann Bovin1, Pia Knudsen2, Maja Hellfritzsch3 & Erik Lerkevang Grove4, 5 1) Hjertesygdomme, Sygehus Lillebælt, Vejle 2) Vidensformidling og Læring, Styrelsen for Patientsikkerhed 3) Klinisk Farmakologi og Farmaci, Institut for Sundhedstjenesteforskning, Syddansk Universitet 4) Hjertesygdomme, Aarhus Universitetshospital 5) Institut for Klinisk Medicin, Aarhus Universitet Ugeskr Læger 2018;180:V03180222
Reference: 
Ugeskr Læger 2018;180:V03180222
Sidetal: 
2-6
Adverse events with oral anticoagulants
Anticoagulant therapy is widely used for prevention and treatment of cardiovascular disease and is frequently prescribed both in primary and secondary care. In comparison to other drugs, the frequency of medication errors is high for anticoagulant therapy. In Denmark, 4,383 adverse events with vitamin K antagonists and 3,234 adverse events with non-vitamin K antagonist oral anticoagulants were reported to the Danish Patient Safety Authority in 2014-2017. In this review, we provide an overview of medication errors and discusses frequent adverse events and pitfalls.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Svend Erik Gundestrup | 15/11
1 Kommentar
af Heidi Ingerslev Jørgensen | 14/11
5 kommentarer
af Peter Tagmose Thomsen | 09/11
1 Kommentar
af Frank Bang Nissen | 09/11
1 Kommentar
af Frank Bang Nissen | 09/11
3 kommentarer
af Klaus Tage Mikal Tobiasen | 05/11
2 kommentarer
af Jørn Rosborg | 05/11
1 Kommentar